Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions remain.

Multiple myeloma ... and harm your kidneys. Myeloma cells crowd out normal blood cells, lowering your red blood cell count, causing anemia and fatigue. Without treatment, these cells continue ...

The Committee for Medicinal Products for Human Use (CHMP) recommended expansion of the Carvykti label to include adult patients with relapsed and refractory multiple myeloma, who have received at ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into optimising anti-CD38 antibody-containing quadruplet regimens (quads) for ...